Alnylam, Inceptive sign up to $2 billion AI drug discovery deal | The Mighty 790 KFGO https://www. byteseu.com/2076860/ # AI # ArtificialIntelligence
Alnylam Pharmaceuticals and Inceptive have entered into a significant collaboration focused on AI-driven drug discovery. The partnership is valued at up to $2 billion and aims to leverage artificial intelligence to accelerate the identification and development of new therapeutics. This deal highlights the growing trend of pharmaceutical companies integrating advanced AI technologies into their research and development pipelines. AI
IMPACT Accelerates AI integration in pharmaceutical R&D, potentially leading to faster drug development cycles.